Duodenal-type follicular lymphoma

Clinical trials for Duodenal-type follicular lymphoma explained in plain language.

Never miss a new study

Get alerted when new Duodenal-type follicular lymphoma trials appear

Sign up with your email to follow new studies for Duodenal-type follicular lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug SGR-1505 enters early human testing for blood cancers

Disease control Recruiting now

This early-phase trial tests a new drug, SGR-1505, in about 98 adults with various B-cell blood cancers (like lymphoma or leukemia) that have not responded to other treatments. The main goals are to find the safest dose and understand side effects. Participants will receive the d…

Matched conditions: DUODENAL-TYPE FOLLICULAR LYMPHOMA

Phase 1 • Sponsor: Schrödinger, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:04 UTC

Duodenal-type follicular lymphoma

Get alerted when new Duodenal-type follicular lymphoma trials appear

New drug SGR-1505 enters early human testing for blood cancers